Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • shaojingwang
    Junior Member
    • May 2010
    • 7

    cDNA read map parameter for gsAssembler

    When I use gsAssembler from 454 to do cDNA assembling, I was confused about this parameter '-rip'.
    '-rip' --> Flag to output each read in only one contig.
    and this option default false.
    As I known for genome assembly, one read should be assembled to only one contig.
    I want to know, for cDNA assembly, reads should be assembled to multiple contigs or not? If yes, i can't understand, who can tell me why. If not, in what situation reads should be assembled to multiple contigs?
    what message can we get by assembling one read to multiple contigs?

    urgent for answer...
  • westerman
    Rick Westerman
    • Jun 2008
    • 1104

    #2
    Interestingly, in Newbler 2.5 (recently released) there is a warning message when using both the -cdna and the -rip switch:

    The -rip option has no effect for cDNA assembly projects.
    After looking at the 2.5 output, it appears to be ripping reads apart. I still need to play around with the 2.5 results a bit more in order to be sure. Thus the answer to your question of "reads should be assembled to multiple contigs or not?" is, at least for Newbler, "yes". As for why, I suspect that it is because Newbler likes making Isotigs which, more or less, represent alternative splicing.

    Comment

    • shaojingwang
      Junior Member
      • May 2010
      • 7

      #3
      Originally posted by westerman View Post
      Interestingly, in Newbler 2.5 (recently released) there is a warning message when using both the -cdna and the -rip switch:



      After looking at the 2.5 output, it appears to be ripping reads apart. I still need to play around with the 2.5 results a bit more in order to be sure. Thus the answer to your question of "reads should be assembled to multiple contigs or not?" is, at least for Newbler, "yes". As for why, I suspect that it is because Newbler likes making Isotigs which, more or less, represent alternative splicing.
      Thanks for reply and sorry for being offline due to the time difference. I still work with Newbler 2.3, maybe I need a uprade.
      I ran a set of sff file using Newbler 2.3 with '-rip' and parallel without '-rip',then compare the result '454IsotigsLayout.txt' and '454ReadStatus.txt' file. Profound differences were found between the two '454IsotigsLayout.txt' file, I am confused by which is more close to the truth.
      Another aspect, even using '-rip' option, '454ReadStatus.txt' file still contain reads assembled to multi contigs, cause difficult to get the expression level.
      I'm still confused about this.
      GK033JC03GCSGP Assembled contig00261 7 + contig00262 281 -
      GK033JC03G0PHY Assembled contig00261 7 + contig00262 436 -
      GK033JC03GNYQQ Assembled contig00261 7 + contig00262 470 -
      GK033JC03G292T Assembled contig00261 1 + contig00262 434 -
      GK033JC03GT171 Assembled contig00261 1 + contig00262 378 -

      Comment

      • flxlex
        Moderator
        • Nov 2008
        • 412

        #4
        Originally posted by shaojingwang View Post
        I want to know, for cDNA assembly, reads should be assembled to multiple contigs or not? If yes, i can't understand, who can tell me why.
        Both for genome assemblies and cDNA assemblies (and contrary to many other assemblers), newbler sometimes places parts of reads in different contigs. The reason why I try to explain in my blog on newbler:
        I thought to start by explaining briefly how newbler works. I’ll do this by following the output newbler generates during the assembly process. This information is displayed during assembly, …


        The -rip option has been discussed previously:
        Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

        Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc


        Best of luck,

        flxlex

        Comment

        • shaojingwang
          Junior Member
          • May 2010
          • 7

          #5
          That's just what I want to know, thank you.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 12:17 PM
          0 responses
          13 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          37 views
          0 reactions
          Last Post SEQadmin2  
          Working...